Identified mortality risk factors associated with presentation, initial hospitalisation, and interstage period for the Norwood operation in a multi-centre registry: a report from the National Pediatric Cardiology-Quality Improvement Collaborative

被引:46
|
作者
Cross, Russell R. [1 ,2 ]
Harahsheh, Ashraf S. [1 ,2 ]
McCarter, Robert [3 ]
Martin, Gerard R. [1 ,2 ]
机构
[1] Childrens Natl Med Ctr, Dept Pediat, Div Cardiol, Washington, DC 20010 USA
[2] Childrens Natl Med Ctr, Div Biostat & Res Methodol, Washington, DC 20010 USA
[3] George Washington Univ, Sch Med, Washington, DC USA
基金
美国医疗保健研究与质量局;
关键词
Hypoplastic left heart syndrome; Norwood; mortality; quality improvement; outcomes; LEFT-HEART SYNDROME; HYPOTHERMIC CIRCULATORY ARREST; JOINT COUNCIL; SURGERY; INFANTS; OUTCOMES; DEATH; RECONSTRUCTION; MANAGEMENT; STENOSIS;
D O I
10.1017/S1047951113000127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Despite improvements in care following Stage 1 palliation, interstage mortality remains substantial. The National Pediatric Cardiology-Quality Improvement Collaborative captures clinical process and outcome data on infants discharged into the interstage period after Stage 1. We sought to identify risk factors for interstage mortality using these data. Materials and methods: Patients who reached Stage 2 palliation or died in the interstage were included. The analysis was considered exploratory and hypothesis generating. Kaplan-Meier survival analysis was used to screen for univariate predictors, and Cox multiple regression modelling was used to identify potential independent risk factors. Results: Data on 247 patients who met the criteria between June, 2008 and June, 2011 were collected from 33 surgical centres. There were 23 interstage mortalities (9%). The identified independent risk factors of interstage mortality with associated relative risk were: hypoplastic left heart syndrome with aortic stenosis and mitral atresia (relative risk = 13), anti-seizure medications at discharge (relative risk = 12.5), earlier gestational age (relative risk = 11.1), nasogastric or nasojejunal feeding (relative risk = 5.5), unscheduled readmissions (relative risk = 5.3), hypoplastic left heart syndrome with aortic atresia and mitral stenosis (relative risk = 5.2), fewer clinic visits with primary cardiologist identified (relative risk = 3.1), and fewer post-operative vasoactive medications (relative risk = 2.2). Conclusion: Interstage mortality remains substantial, and there are multiple potential risk factors. Future efforts should focus on further exploration of each risk factor, with potential integration of the factors into surveillance schemes and clinical practice strategies.
引用
收藏
页码:253 / 262
页数:10
相关论文
共 4 条
  • [1] Center Variability in Timing of Stage 2 Palliation and Association with Interstage Mortality: A Report from the National Pediatric Cardiology Quality Improvement Collaborative
    Hill, Garick D.
    Rudd, Nancy A.
    Ghanayem, Nancy S.
    Hehir, David A.
    Bartz, Peter J.
    PEDIATRIC CARDIOLOGY, 2016, 37 (08) : 1516 - 1524
  • [2] Improved Variation in Interstage Weight Gain After the Norwood Operation: A Report From the National Pediatric Cardiology Quality Improvement Collaborative
    Anderson, Jeff
    Beekman, Robert
    Kugler, John
    Rosenthal, Geoffrey
    Jenkins, Kathy
    Klitzner, Tom
    Martin, Gerard
    Neish, Steven
    Darbie, Lynn
    King, Eileen
    Lannon, Carole
    CIRCULATION, 2013, 128 (22)
  • [3] Center Variability in Timing of Stage 2 Palliation and Association with Interstage Mortality: A Report from the National Pediatric Cardiology Quality Improvement Collaborative
    Garick D. Hill
    Nancy A. Rudd
    Nancy S. Ghanayem
    David A. Hehir
    Peter J. Bartz
    Pediatric Cardiology, 2016, 37 : 1516 - 1524
  • [4] Is Clinic Visit Frequency Associated with Weight Gain During the Interstage Period? A Report from the Joint Council on Congenital Heart Disease National Pediatric Cardiology Quality Improvement Collaborative (JCCHD-NPCQIC)
    Hurst D.M.
    Oster M.E.
    Smith S.
    Clabby M.L.
    Pediatric Cardiology, 2015, 36 (7) : 1382 - 1385